Evidence map›Paper›PMID 40755465›Full record

ReviewInternational journal of nanomedicine2025

Implication of Bimodal Magnetic Resonance and Fluorescence Imaging Probes in Advanced Healthcare: Enhancing Disease Diagnosis and Targeted Therapy.

Tingting Gong, Zia Ullah, Shubham Roy, Caixue Cheng, Menglong Li, Jing Cheng, Yinghe Zhang, Bing Guo, Yingwei Qiu

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Contrast Agents for Enhanced Bioimaging: A Comprehensive Review.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tingting Gong *Department of Radiology, Shenzhen Nanshan People's Hospital (NSPH), Shenzhen, Guangdong, People's Republic of China.
Zia Ullah *School of Science, Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen, Guangdong, People's Republic of China.
Shubham RoySchool of Science, Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen, Guangdong, People's Republic of China.ORCID 0000-0001-5245-3229
Caixue ChengDepartment of Radiology, Shenzhen Nanshan People's Hospital (NSPH), Shenzhen, Guangdong, People's Republic of China.ORCID 0009-0004-8958-7748
Menglong LiDepartment of Radiology, Shenzhen Nanshan People's Hospital (NSPH), Shenzhen, Guangdong, People's Republic of China.
Jing ChengEducation Center and Experiments and Innovations, Harbin Institute of Technology, Shenzhen, Guangdong, People's Republic of China.
Yinghe ZhangSchool of Science, Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen, Guangdong, People's Republic of China.
Bing GuoSchool of Science, Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen, Guangdong, People's Republic of China.ORCID 0000-0001-7981-0644
Yingwei QiuDepartment of Radiology, Shenzhen Nanshan People's Hospital (NSPH), Shenzhen, Guangdong, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular imaging probes hold great promise in disease diagnostics and their therapeutic interventions. However, a single imaging modality sometimes lacks efficiency in all kinds of diseases. Conditions such as cancer, cardiovascular disorders, and neurodegenerative diseases critically require multimodal imaging to characterize complex biological environments accurately. Efficient targeting further enhances probe performance, improving diagnostic precision. This study explores the design rationale and application of bimodal probes designed for Magnetic Resonance (MR) and fluorescence (FL) imaging for their complementary strengths. MRI enables deep tissue visualization, while fluorescence offers high sensitivity and cellular-level resolution. Meticulous attention has been devoted to presenting methodologies aimed at improving the targeting efficacy of these probes. This involves the methodology to enhance targeting efficacy, including ligand-based strategies, nanoparticle functionalization, and molecularly imprinted polymers. The probes combine fluorescence for precise cellular imaging with MRI for in-depth tissue visualization, providing synergistic benefits that elevate their diagnostic potential. Moreover, we offer recent developments in Machine Learning and Artificial Intelligence-based computational approaches for image analysis, enabling more precise diagnosis across a range of diseases that may propel their diagnostic abilities for better therapeutic outcomes. Through systematic analysis and in vitro and in vivo evaluations, we demonstrate the ability of the probes to achieve superior spatial and temporal resolution, facilitating the accurate delineation of biological targets. The integration of these bimodal probes holds great promise for advancing our understanding of complex biological processes, enabling more precise diagnostics, and paving the way for targeted therapeutic interventions.

Indexed as

Magnetic Resonance ImagingMolecular ImagingMolecular Targeted TherapyMultimodal ImagingOptical ImagingAnimalsCardiovascular DiseasesFluorescent DyesHumansImage Interpretation, Computer-AssistedMachine LearningNanoparticlesNeoplasmsNeurodegenerative DiseasesFluorescent Dyesbimodal imagingfluorescence imagingmagnetic resonance imagingmolecular imaging probestargeting

Identifiers

PMID40755465
PMCPMC12317703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.